Press Releases

FARMINGTON, Conn. , Oct. 17, 2017 /PRNewswire/ --  Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") ("Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare...

Origination Platform and Active Lending Environment Drive Investment Activity and Increase Committed Backlog...

FARMINGTON, Conn. , Sept. 29, 2017 /PRNewswire/ --  Horizon Technology Finance Corporation (Nasdaq: HRZN) (the "Company" or "Horizon") announced today that it will redeem its 7.375% Senior Notes due 2019 ( NYSE : HTF) (the "Notes"). The Company will redeem 100%, or $33,000,000 aggregate principal...

FARMINGTON, Conn. , Sept. 26, 2017 /PRNewswire/ -- Horizon Technology Finance Corporation (Nasdaq: HRZN) (the "Company" or "Horizon") announced today that it has priced an underwritten public offering of $32.5 million aggregate principal amount of notes due 2022 (the "Notes"), which will result in...

FARMINGTON, Conn. , Sept. 26, 2017 /PRNewswire/ --  Horizon Technology Finance Corporation (Nasdaq: HRZN) (the "Company" or "Horizon") announced today that it has commenced an underwritten public offering of $30.0 million aggregate principal amount of notes due 2022 (the "Notes")....

FARMINGTON, Conn. , Aug. 24, 2017 /PRNewswire/ --  Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") ("Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare...

FARMINGTON, Conn. and PHILADELPHIA , Aug. 14, 2017 /PRNewswire/ --  Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") ("Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life...

FARMINGTON, Conn. , Aug. 1, 2017 /PRNewswire/ --  Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and...

Strong Investment Activity Leads to Increased Committed Backlog;<br>Liquidity Events Contributed to Annualized Portfolio Yield of 14.7%...

SOUTH SAN FRANCISCO, Calif. , July 27, 2017 /PRNewswire/ --  Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, continuous drug delivery technology,...